Literature DB >> 25199005

Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?

H R Shivaramakrishna1, A Frederick2, A Shazia1, L Murali3, S Satyanarayana4, S A Nair1, A M Kumar4, P K Moonan5.   

Abstract

SETTING: Two districts of Tamil Nadu, India
OBJECTIVES: To determine the proportion of household contacts aged <6 years of patients with tuberculosis (TB) with positive sputum microscopy results who initiated and completed isoniazid preventive treatment (IPT), and to determine reasons for non-initiation and non-completion of IPT.
DESIGN: Household visits were conducted on a random sample of adult patients registered during January-June 2012 to identify household contacts aged <6 years.
RESULTS: Among 271 children living with 691 index patients, 218 (80%) were evaluated and 9 (4%) were diagnosed with TB. Of 209 remaining contacts, 70 (33%) started IPT and 16 (22.9%) completed a full course of IPT. Of 139 contacts who did not start IPT, five developed TB disease. Reasons for non-initiation of IPT included no home visit by the field staff (19%) and no education about IPT (61%). Reasons for non-completion included isoniazid not provided (52%) and long duration of treatment (28%).
CONCLUSION: This study shows that Revised National TB Programme guidance was not being followed and IPT implementation was poor. Poor IPT uptake represents a missed opportunity to prevent future TB cases. Provision of IPT may be improved through training, improved logistics and enhanced supervision and monitoring.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199005      PMCID: PMC4589200          DOI: 10.5588/ijtld.14.0072

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  21 in total

1.  Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.

Authors:  Dick Menzies; Marie-Josée Dion; Barry Rabinovitch; Sharyn Mannix; Paul Brassard; Kevin Schwartzman
Journal:  Am J Respir Crit Care Med       Date:  2004-06-01       Impact factor: 21.405

2.  Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-09       Impact factor: 17.586

Review 3.  Screening and preventive therapy for tuberculosis.

Authors:  Ben J Marais; Helen Ayles; Stephen M Graham; Peter Godfrey-Faussett
Journal:  Clin Chest Med       Date:  2009-12       Impact factor: 2.878

4.  Adherence to isoniazid preventive chemotherapy: a prospective community based study.

Authors:  B J Marais; Susan van Zyl; H S Schaaf; M van Aardt; R P Gie; N Beyers
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

5.  Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

Authors:  Kathleen R Page; Frangiscos Sifakis; Ruben Montes de Oca; Wendy A Cronin; Meg C Doherty; Lynn Federline; Sarah Bur; Thomas Walsh; Walter Karney; James Milman; Nancy Baruch; Akintoye Adelakun; Susan E Dorman
Journal:  Arch Intern Med       Date:  2006-09-25

6.  Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.

Authors:  Alfred Lardizabal; Marian Passannante; Faysal Kojakali; Christopher Hayden; Lee B Reichman
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

Review 7.  Global epidemiology of childhood tuberculosis.

Authors:  L J Nelson; C D Wells
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

8.  Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration.

Authors:  Madhavi Pothukuchi; Sharath Burugina Nagaraja; Santosha Kelamane; Srinath Satyanarayana; Sai Babu; Puneet Dewan; Fraser Wares
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

9.  A six months follow-up on children less than 6 years old in contact with smear positive tuberculosis patients, varamin city, tehran, iran.

Authors:  Zohreh Aminzadeh; Rahim Taghizadeh Asl
Journal:  Int J Prev Med       Date:  2011-04

10.  Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation.

Authors:  Merrin E Rutherford; Rovina Ruslami; Winni Maharani; Indria Yulita; Sarah Lovell; Reinout Van Crevel; Bachti Alisjahbana; Philip C Hill
Journal:  BMC Res Notes       Date:  2012-01-06
View more
  20 in total

Review 1.  Quality of tuberculosis care in India: a systematic review.

Authors:  S Satyanarayana; R Subbaraman; P Shete; G Gore; J Das; A Cattamanchi; K Mayer; D Menzies; A D Harries; P Hopewell; M Pai
Journal:  Int J Tuberc Lung Dis       Date:  2015-07       Impact factor: 2.373

2.  A review of tuberculosis contact investigations in the poor urban areas of Manila, The Philippines.

Authors:  L Coprada; S Yoshimatsu; A Querri; E Lopez; P Agujo; M R Paulino; A Medina; A M C Garfin; A Ohkado
Journal:  Public Health Action       Date:  2016-12-21

3.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

4.  A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.

Authors:  D G Datiko; M A Yassin; S J Theobald; L E Cuevas
Journal:  Int J Tuberc Lung Dis       Date:  2017-09-01       Impact factor: 2.373

5.  Evaluation of TB Case Finding through Systematic Contact Investigation, Chhattisgarh, India.

Authors:  Kshitij Khaparde; Pawan Jethani; Puneet K Dewan; Sreenivas A Nair; Madhav Rao Deshpande; Srinath Satyanarayana; Shamim Mannan; Patrick K Moonan
Journal:  Tuberc Res Treat       Date:  2015-07-06

6.  Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point.

Authors:  Yared Tadesse; Nigussie Gebre; Shallo Daba; Zewdu Gashu; Dereje Habte; Nebiyu Hiruy; Solomon Negash; Kassahun Melkieneh; Degu Jerene; Yared K Haile; Yewulsew Kassie; Muluken Melese; Pedro G Suarez
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

7.  Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis.

Authors:  Dick D Chamla; Chukwuemeka Asadu; Abiola Davies; Arjan de Wagt; Oluwafunke Ilesanmi; Daniel Adeyinka; Ebun Adejuyigbe
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

Review 8.  Child contact management in high tuberculosis burden countries: A mixed-methods systematic review.

Authors:  Daria Szkwarko; Yael Hirsch-Moverman; Lienki Du Plessis; Karen Du Preez; Catherine Carr; Anna M Mandalakas
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

9.  Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination.

Authors:  Andrea DeLuca; Gauri Dhumal; Mandar Paradkar; Nishi Suryavanshi; Vidya Mave; Rewa Kohli; Shri Vijay Bala Yogendra Shivakumar; Vidula Hulyolkar; Archana Gaikwad; Ashwini Nangude; Geeta Pardeshi; Dileep Kadam; Amita Gupta
Journal:  BMC Infect Dis       Date:  2018-05-02       Impact factor: 3.090

10.  Implementation of Isoniazid Preventive Therapy Among HIV-Infected Children at Health Facilities in Nairobi County, Kenya: A Cross-Sectional Study.

Authors:  Peninah M Mwangi; Dalton Wamalwa; Diana Marangu; Elizabeth M Obimbo; Murima Ng'ang'a
Journal:  East Afr Health Res J       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.